Together with our customers, we unlock the potential of blood and cellular therapies to enable better lives
The Blood Management Company provides a wide range of products: Instruments for blood centers that separate and produce blood components for transfusions, using blood from donors; instruments used to treat patients with illnesses through cell therapy and therapeutic apheresis; and even biotech and cell processing equipment used in research institutions. As one of Terumo's three pillar companies, the Blood Management Company, led by a Terumo Group subsidiary in the United States, Terumo BCT*, contributes to the lives and quality of life of patients in over 130 countries and regions around the world, and to medical settings that function in the blood and cell fields.
With a spirit of collaboration with medical settings and compassion for patients, Terumo BCT pursues unique technologies to bring about better quality transfusions, blood treatments, and cell therapies.
Terumo BCT, Inc.; joined the Terumo Group in 2011
Note: The regulatory approval status and availability of these products differs by country or region.
Blood Center Business
Donated blood is utilized to treat patients with illnesses or injuries, in the form of platelets, plasma, red bood cells, or other blood components. Blood centers produce blood components and supply them to medical institutions.
Terumo BCT contributes to the global blood supply by providing blood centers with blood collection instruments, disposable collection sets, whole blood bags, and the devices used to produce blood components. The company also improves blood safety by providing transfusion systems that reduce pathogens that cannot be detected in blood product tests, and that inactivate residual leukocytes.
Whole blood collection
Blood separation and component production
Pathogen reduction technology
Therapeutic Apheresis and Cell Collection
Terumo BCT provides a centrifugal apheresis system that provides multiple procedures for the exchange, collection, depletion and processing of cells. These procedures can be used in the treatment of various diseases, including sickle cell disease, cancer, myasthenia gravis.
Cell Therapy Technologies
Terumo BCT provides cell processing systems that efficiently wash, separate, concentrate and culture the cells needed for research, industrial and clinical uses. We enable cell therapy development that has the potential to fundamentally improve healthcare.
By harnessing the potential of a patient’s own plasma, bone marrow or adipose tissue, physicians can now offer alternative options to their patients. Harvest Technologies, which joined Terumo BCT in 2015, provides the medical device and process disposables used to collect, separate and concentrate these cells for use. (Not sold in Japan.)